Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions
- PMID: 22218286
- PMCID: PMC3391585
- DOI: 10.1016/j.biopsych.2011.11.022
Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions
Abstract
Background: Cumulative adversity and stress are associated with risk of psychiatric disorders. While basic science studies show repeated and chronic stress effects on prefrontal and limbic neurons, human studies examining cumulative stress and effects on brain morphology are rare. Thus, we assessed whether cumulative adversity is associated with differences in gray matter volume, particularly in regions regulating emotion, self-control, and top-down processing in a community sample.
Methods: One hundred three healthy community participants, aged 18 to 48 and 68% male, completed interview assessment of cumulative adversity and a structural magnetic resonance imaging protocol. Whole-brain voxel-based-morphometry analysis was performed adjusting for age, gender, and total intracranial volume.
Results: Cumulative adversity was associated with smaller volume in medial prefrontal cortex (PFC), insular cortex, and subgenual anterior cingulate regions (familywise error corrected, p < .001). Recent stressful life events were associated with smaller volume in two clusters: the medial PFC and the right insula. Life trauma was associated with smaller volume in the medial PFC, anterior cingulate, and subgenual regions. The interaction of greater subjective chronic stress and greater cumulative life events was associated with smaller volume in the orbitofrontal cortex, insula, and anterior and subgenual cingulate regions.
Conclusions: Current results demonstrate that increasing cumulative exposure to adverse life events is associated with smaller gray matter volume in key prefrontal and limbic regions involved in stress, emotion and reward regulation, and impulse control. These differences found in community participants may serve to mediate vulnerability to depression, addiction, and other stress-related psychopathology.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Dr. Guarnaccia has served on the speaker panel and as a consultant for Biogen, Inc; Teva Pharmaceuticals; Accorda Pharmaceuticals; Pfizer, Inc; Serono, Inc; Bayer Pharmaceuticals; and Abbott Pharmaceuticals. Dr. Sinha is on the Scientific Advisory Board for Embera Neurotherapeutics and is also a consultant for Glaxo-Smith Kline Pharmaceuticals. All other authors reported no biomedical financial interests or potential conflicts of interest.
Figures



References
-
- Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389. - PubMed
-
- Turner RJ, Lloyd DA. Cumulative adversity and drug dependence in young adults: Racial/ethnic contrasts. Addiction. 2003;98:305–315. - PubMed
-
- Turner RJ, Lloyd DA. The stress process and the social distribution of depression. J Health Soc Behav. 1999;40:374–404. - PubMed
-
- Turner RJ, Wheaton B. Checklist measurement of stressful life events. In: Cohen S, Kessler R, Underwood GL, editors. Measuring Stress. New York: Oxford University Press; 1995. pp. 29–58.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous